Trending: On-device modelsSearch
iHeartGeek
iTECH

IFA 2026: ZenoWell puts vagus-nerve stimulation in a wearable for sleep and stress

ZenoWell is showcasing its ear-based vagus-nerve stimulation devices at IFA 2026, including the AI-assisted Luna Plus, designed to support sleep, relaxation and recovery.

ZenoWell Luna Plus vagus-nerve stimulation device, wearable band and companion smartphone app shown together on a white background.

The wellness aisle is getting increasingly inventive about how it promises to calm us down. ZenoWell’s answer is to send gentle electrical stimulation through the ear and ask the vagus nerve to help restore order.

At IFA 2026, ZenoWell is showcasing a range of auricular vagus-nerve stimulation, or taVNS, devices. The lineup includes the ZenoWell Luna, Vita Mini and Luna Plus, which the company describes as an AI-powered wearable system for a smarter daily reset.

Unlike implanted vagus-nerve stimulators, ZenoWell’s devices are designed to sit around the ear and deliver non-invasive electrical impulses to areas associated with the auricular branch of the vagus nerve. The company says the approach is intended to support better sleep, reduced stress, focus and recovery.

What’s actually going on

ZenoWell’s products are built around transcutaneous auricular vagus-nerve stimulation, known as taVNS. The company says its devices target the vagus nerve through the ear using gentle electrical pulses, with users typically experiencing light tingling, tapping, pulsing or vibration.

The Luna Plus adds a broader data and software layer. ZenoWell says its Luna Plus Set combines the stimulation device with the Zenoband Mobi, a Face Scan in the Zeno app and an AI Coach. The system is intended to bring together signals such as heart rate, heart-rate variability and sleep data, then use them to suggest routines for sleep, stress, focus, digestion and recovery.

ZenoWell’s website promotes claims including deeper sleep, lower stress and improved HRV with daily use. These are company marketing claims, not results we have independently tested. Nor should the devices be treated as replacements for medical advice or clinically prescribed treatment.

The German ZenoWell storefront lists the Luna Plus at €505, reduced from a stated regular price of €587.33. The Luna is listed at €359.95 and the Vita at €209.95, although prices and availability may vary by country and IFA promotion.

Why you should care

The appeal is obvious: taVNS offers a drug-free and non-invasive wellness routine that can be performed at home. Adding wearable data and an AI coach could make sessions feel more personalised than pressing “relax” in an app and hoping for the best.

The challenge is proving that the personalisation genuinely improves outcomes. HRV and sleep measurements can be useful indicators, but they are not magical health scores, and an AI recommendation is only as good as the data and reasoning behind it.

Our opinion

When we spoke to ZenoWell’s CEO at IFA 2026, he told us that several studies conducted by the company had produced very positive results. That is an encouraging claim, but it remains a company-reported statement: without seeing the study designs, participant numbers, results and independent review, it should not be treated as independently proven evidence.

ZenoWell’s approach is interesting because it sits between consumer wellness and medical technology. A comfortable, non-invasive ear-based device could appeal to people who want something more structured than meditation but less demanding than a clinical intervention.

However, the health claims need careful scrutiny. ZenoWell still needs to make clear what has been independently demonstrated, what is still being studied and which users should avoid stimulation devices. For now, ZenoWell looks like a fascinating piece of wearable neurotechnology — but one to approach with curiosity rather than blind faith.